BioWorld Asia

Sep. 5, 2007

Acambis Wins FDA Approval For New Smallpox Vaccine

Acambis plc has won FDA approval for its smallpox vaccine ACAM 2000, the first new biodefense vaccine to be licensed since the U.S. government launched Project Bioshield in 2001. (BioWorld International) Read More

Jerini Goes Solo With Icatibant In U.S. As Abbott Walks Out

Speedel, Novartis Extending SPP100 Into Heart Failure

Forest Terminates Interest In Paion's Desmoteplase

Generic Epoetin Products Win Approval From EU

Other News To Note

Immutep Tests Lead Compound ImmuFact IMP321 In Melanoma

Heptares Spun Out of MRC To Become A Standalone

Trophos Raises €8.5M To Move Compound Into Phase II Trials

No Abstract Read More

Today's news in brief

BioWorld

BioWorld briefs for Dec. 31, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 31, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

BioWorld

Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...

Big pharma taps fast Asia innovation in search of next Keytruda

BioWorld

Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...